Equity Research, Broker Reports, and media content on MaxCyte

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about MaxCyte
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on MaxCyte. We currently have 68 research reports from 5 professional analysts.

Open
130p
Range Today
125/132p
52 Week
108/188p
Daily Volume
1.6k
# Shares
51.4m
Daily Liquidity
(0.00%)
Pension Liability
£0m
Enterprise Value
£76.5m
Market Cap
£66.8m
Latest PE (hist)
Div Yield
Date Source Announcement
24Mar20 07:00 RNS License Agreement with Allogene Therapeutics
21Feb20 07:00 RNS Consolidation of Trading Lines
20Feb20 18:18 RNS AIM Block Admission Return / Total Voting Rights
05Feb20 07:00 RNS-R MaxCyte to Present at BIO CEO & Investor Conf
24Jan20 16:31 RNS Grant Of Options
22Jan20 17:15 RNS Holding(s) in Company
22Jan20 17:11 RNS Holding(s) in Company
  • Frequency of research reports

     

  • Research reports on

    MaxCyte

  • Providers covering

    MaxCyte